Cite
[Octreotide long acting release for severe obscure gastrointestinal haemorrhage in elderly patients with serious comorbidities]
MLA
Javier, Molina Infante, et al. “[Octreotide Long Acting Release for Severe Obscure Gastrointestinal Haemorrhage in Elderly Patients with Serious Comorbidities].” Medicina Clinica, vol. 133, no. 17, Apr. 2009. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........b79a95d65940118edbd68b9982b3ce40&authtype=sso&custid=ns315887.
APA
Javier, M. I., Belén, P. G., Moisés, H. A., José María, M. R., Carmen, D. S., & Miguel, F. B. (2009). [Octreotide long acting release for severe obscure gastrointestinal haemorrhage in elderly patients with serious comorbidities]. Medicina Clinica, 133(17).
Chicago
Javier, Molina Infante, Pérez Gallardo Belén, Hernández Alonso Moisés, Mateos Rodríguez José María, Dueñas Sadornil Carmen, and Fernández Bermejo Miguel. 2009. “[Octreotide Long Acting Release for Severe Obscure Gastrointestinal Haemorrhage in Elderly Patients with Serious Comorbidities].” Medicina Clinica 133 (17). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........b79a95d65940118edbd68b9982b3ce40&authtype=sso&custid=ns315887.